Literature DB >> 913969

Cancer in colitis: assessment of the individual risk by clinical and histological criteria.

J E Lennard-Jones, B C Morson, J K Ritchie, D C Shove, C B Williams.   

Abstract

The cancer risk among 229 patients with extensive ulcerative colitis observed during January 1, 1966 to February 29, 1976 is correlated with the length of history and the histological findings in rectal and colonic biopsies. Five patients are known to have developed carcinoma. No carcinoma was observed in 578 patient years of follow-up within 10 years of onset of the colitis, but the risk in the second decade was approximately 1 in 200 patient years and in the third, 1 in 60 patient years. Severe epithelial dysplasia was rare and found in 32 biopsies from 13 patients. No carcinoma has occurred during the period of follow-up in patients without dysplasia. It has not been possible to follow the development of dysplasia in sequential biopsies. Seven patients with consistent severe dysplasia on biopsy have been treated surgically; carcinoma confined to the bowel wall (Dukes' A) was found in 4. A scheme of management for patients with extensive colitis, including regular rectal and colonic biopsies, is proposed. Our results suggest that such a program will isolate a small group of patients who require surgical treatment for established precancerous change or carcinoma with a high likelihood of cure.

Entities:  

Mesh:

Year:  1977        PMID: 913969

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  53 in total

1.  Ki-67: a useful marker for the evaluation of dysplasia in ulcerative colitis.

Authors:  S N Andersen; T O Rognum; A Bakka; O P Clausen
Journal:  Mol Pathol       Date:  1998-12

Review 2.  Inflammatory bowel disease and cancer.

Authors:  B Cola
Journal:  Int J Colorectal Dis       Date:  1989       Impact factor: 2.571

Review 3.  Colonoscopic surveillance in ulcerative colitis--dysplasia through the looking glass.

Authors:  J B Fozard; M F Dixon
Journal:  Gut       Date:  1989-03       Impact factor: 23.059

Review 4.  Screening for gastrointestinal cancer: an epidemiological review.

Authors:  J Weil; M J Langman
Journal:  Gut       Date:  1991-02       Impact factor: 23.059

5.  Histopathological changes, mucin production and cellular DNA content in rectal mucosa of patients with ulcerative colitis: a comparison between findings in adults and adolescents.

Authors:  K Matsumoto; S Moriyama; Y Iwata; T Masuda; K Matsumoto; K Iriyama
Journal:  Jpn J Surg       Date:  1986-11

6.  Value of sigmoidoscopy and biopsy in detection of carcinoma and premalignant change in ulcerative colitis.

Authors:  R H Riddell; B C Morson
Journal:  Gut       Date:  1979-07       Impact factor: 23.059

7.  Ulcerative colitis: the fate of the retained rectum.

Authors:  Adam Juviler; Neil Hyman
Journal:  Clin Colon Rectal Surg       Date:  2004-02

8.  The risk of cancer following colectomy and ileorectal anastomosis for extensive mucosal ulcerative colitis.

Authors:  S F Grundfest; V Fazio; R A Weiss; D Jagelman; I Lavery; F L Weakley; R B Turnbull
Journal:  Ann Surg       Date:  1981-01       Impact factor: 12.969

9.  Leukocyte adherence inhibition in patients with nonmalignant disorders of the colon and colorectal cancer.

Authors:  B Tank; R L Marquet; E Vennemans; D L Westbroek
Journal:  J Cancer Res Clin Oncol       Date:  1986       Impact factor: 4.553

10.  Survival with carcinoma arising in mucosal ulcerative colitis.

Authors:  I C Lavery; R A Chiulli; D G Jagelman; V W Fazio; F L Weakley
Journal:  Ann Surg       Date:  1982-04       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.